Benchmark sees revenues up 25% for H1
Aquaculture biotech group Benchmark saw its revenues for the six months to 31 March 2023 go up, year on year, by 25% to £98.9m. The period, the first half of […] Continue Reading
Benchmark says 2022 profits will beat forecast
Aquaculture biotechnology business Benchmark says its profits for the year to 30 September 2022 are set to exceed market expectations. The company’s latest trading update, ahead of the audited full […] Continue Reading
Lice treatment helps Benchmark double profits
Aquaculture biotech company Benchmark has reported revenue up by a third and doubled its adjusted profits for the first half of the current financial year. In its interim report, Benchmark’s […] Continue Reading
Benchmark reports strong growth in Q3
Genetics and animal health specialist Benchmark Group saw its revenue and profits surging back in the third quarter of this year, with strong performance in all areas, especially the sale […] Continue Reading
Benchmark sees revenues up for H1
Aquaculture biotechnology company Benchmark saw group revenues and adjusted EBITDA up for the first half of its 2021 financial year, after a period that saw considerable restructuring of the business. […] Continue Reading
Benchmark’s CleanTreat set for launch in Q2
Biotech group Benchmark Holdings is looking to roll out its novel sea lice treatment, CleanTreat, in the second quarter of this year. The announcement came as the group also reported […] Continue Reading
Benchmark ‘transformed’ by acquisition
THE Benchmark Group said 2016 was a ‘transformative’ year, which saw it encompass genetics, egg production, specialist nutrition and the provision of veterinary services and health products for the global […] Continue Reading